Cipla says top 50 drugs in development could bring in $30B

John Carroll

Indian drugmaker said it currently has 200 in and that the top 50 of those have the potential to earn the company more than $ 30 billion.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS